# Shandong Anhong Pharmaceutical Co., Ltd. – FDA Inspection, Feb 22, 2019

Source: https://www.keypedia.com/records/fda_inspections/shandong-anhong-pharmaceutical-co-ltd/8b8439c6-6656-45ee-aba1-007a022eb5f5
Source feed: FDA_Inspections

> FDA inspection 1081775 of Shandong Anhong Pharmaceutical Co., Ltd., February 22, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1081775
- Company Name: Shandong Anhong Pharmaceutical Co., Ltd.
- Inspection Date: 2019-02-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 983627 - 2016-09-02](https://www.keypedia.com/records/fda_inspections/shandong-anhong-pharmaceutical-co-ltd/49ead6f2-67d4-4179-98a0-75536c335df6)
- FDA Inspection 851827 - 2013-09-13

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/joel-d-hustedt/29440042-08dd-4dce-be48-b55f8e1d7080)

Company: https://www.keypedia.com/companies/shandong-anhong-pharmaceutical-co-ltd/3b784225-cf8c-4bc5-a5ad-b5e47f484f59

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c